Related Experiment Video
Updated: Oct 8, 2025

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
Published on: February 28, 2025
Hypoglycemic flavonoids from Selaginella tamariscina (P.Beauv.) Spring
Hong-Ping Long1, Jian Liu2, Ping-Sheng Xu3
1The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, PR China; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR China.
Researchers isolated novel flavonoids from Selaginella tamariscina, with three compounds showing significant hypoglycemic activity by increasing glucose consumption and upregulating key proteins, suggesting potential for diabetes treatment.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Metabolic Diseases
Background:
- Selaginella tamariscina is a plant source of bioactive compounds.
- Flavonoids are known for diverse biological activities, including potential metabolic benefits.
- Understanding the hypoglycemic effects of plant-derived compounds is crucial for diabetes research.
Purpose of the Study:
- To isolate and characterize novel flavonoid compounds from Selaginella tamariscina.
- To evaluate the hypoglycemic activity of these isolated compounds in vitro.
- To investigate the molecular mechanisms underlying the observed hypoglycemic effects.
Main Methods:
- Isolation and purification of compounds using chromatographic techniques.
- Structure elucidation of novel compounds via Nuclear Magnetic Resonance (NMR) spectroscopy, High-Resolution Electrospray Ionization Mass Spectrometry (HRESIMS), and Electronic Circular Dichroism (ECD) analyses.
- In vitro assessment of hypoglycemic activity in HepG2 cells (normal and insulin-resistant) and Western blot analysis for protein expression (glucokinase and adenylate cyclases).
Main Results:
- Six flavonoids were isolated, including three new biflavonoids and one new 8-aryl flavonoid.
- Involvenflavone H, I, and J demonstrated significant increases in glucose consumption in HepG2 cells.
- These active compounds upregulated the protein expression of glucokinase (GCK) and adenylate cyclases (ADCYs).
Conclusions:
- Involvenflavone H, I, and J possess potent hypoglycemic activity, with involvenflavone J being particularly effective.
- The mechanism involves enhanced glucose uptake and upregulation of GCK and ADCYs.
- These flavonoids represent promising therapeutic leads for managing diabetes.
More Related Videos
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Sulfonylureas
Oral Hypoglycemic Agents: Biguanides and Glitazones
Hypoglycemia and Glucagon

